Article Information
History
- March 10, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Richard Osei-Yeboah1,*,
- Peter Spreeuwenberg2,
- Marco Del Riccio2,3,
- Thea K. Fischer4,5,
- Amanda Cavling4,5,
- Håkon Boas6,
- Michiel van Boven7,8,
- Xin Wang9,
- Toni Lehtonen10,
- Mathieu Bangert11,
- Harry Campbell1,
- John Paget2 and
- the RESCEU investigators
- 1Centre for Global Health, Usher Institute, University of Edinburgh, Edinburgh, UK
- 2Netherlands Institute for Health Services Research (Nivel), Utrecht, The Netherlands
- 3Postgraduate Medical School in Public Health, University of Florence, 50134 Florence, Italy
- 4Statens Serum Institut, Copenhagen, Denmark
- 5Departments of Clinical Research Nordsjaellands Hospital, Hilleroed and Public Health, University of Copenhagen, Denmark
- 6Department of Infection Control and Vaccines, Norwegian Institute of Public Health, Oslo, Norway
- 7Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands
- 8Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
- 9School of Public Health, Nanjing Medical University, Nanjing, China
- 10Department of Health Security, Finnish Institute for Health and Welfare (THL), Helsinki, Finland
- 11Sanofi Vaccines, Lyon, France
- ↵*Corresponding author
Richard Osei-Yeboah, Centre for Global Health, Usher Institute, University of Edinburgh, Edinburgh, UK, Email:
Richard.Osei-Yeboah{at}ed.ac.uk
Posted March 10, 2023.
Estimation of the number of RSV-associated hospitalisations in adults in the European Union
